| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
IRI
|
Business associate |
1
|
1 | |
|
organization
EasyJoint Project
|
Financial |
1
|
1 |
This page from a Cowen market research report, dated February 25, 2019, analyzes the regulatory environment and market trends for CBD and hemp products in Switzerland and France. It details Swiss regulations regarding cosmetic products and recent corporate consolidations (LGC Capital, Wayland, Creso Pharma), while noting France's status as a leading hemp cultivator despite strict government crackdowns on retail CBD sales. The document bears a House Oversight Committee stamp, suggesting it was part of a congressional document production.
This document is page 82 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the cannabis and hemp markets in Italy and Switzerland. It details regulatory environments, specifically the 'cannabis light' market in Italy and medical/tobacco substitute regulations in Switzerland, while listing various corporate investments and acquisitions (Wayland, Canopy, CROP). The document bears a 'HOUSE_OVERSIGHT_024898' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely included in a larger batch of financial records.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity